NVAX Stock Price
NVAX
NVAX stock price is $10.37 (+7.13% on the day), giving NVAX a market cap of $1.57B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
NVAX Stock Overview
- Price
- $10.37
- Previous close
- $9.68
- Open
- $10.01
- Market cap
- $1.57B
- 1-year price target
- $14.20
- MarketXLS Rank
- 44
About NVAX
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVAX | $10.37 | +7.1% | 3.68M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |